The majority of T1D patients and a small portion of T2D patients in the United States rely on battery-powered infusion pumps for insulin delivery, while the rest of insulin-dependent patients rely on cannula-driven insulin syringes or pens [8, 32]. The gene discussed is INS; the disease is type 1 diabetes mellitus.